ArticleFrontiers in endocrinology2025
Early diagnosis and risk factors of diabetic peripheral neuropathy in type 1 diabetes: insights from current perception threshold testing.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Efficacy and Safety of Dorsal Root Ganglion Pulse Radiofrequency Combined With Sympathetic Radiofrequency Ablation in the Treatment of Acute Herpetic Neuralgia.The Clinical journal of pain · 2026Trial
- Changes in tactile acuity and their association with balance impairment in type 2 diabetes: A 2-year cohort study.Diabetology & metabolic syndrome · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study investigates nerve fiber dysfunction in type 1 diabetes (T1D) patients and identifies risk factors for diabetic peripheral neuropathy (DPN). It evaluates the relationship between current perception threshold (CPT) tests and nerve conduction velocity (NCV), and assesses CPT's diagnostic accuracy for early DPN detection. Research design and methods: This study enrolled 110 patients with T1D and 26 healthy controls between January 2020 and December 2021, in accordance with predefined inclusion/exclusion criteria. CPT testing at 2000 Hz, 250 Hz, and 5 Hz assessed Aβ, Aδ, and C fiber function, while NCV was measured in 47 patients. Subgroups were stratified by disease duration (>5 years vs ≤5 years). Multivariate logistic regression identified DPN risk factors, and CPT-NCV correlation was analyzed using Chi-square and Kappa tests. Receiver operating characteristic (ROC) curves evaluated CPT diagnostic efficacy. Results: The incidence of DPN in 110 T1D patients was 78%, with no significant difference between disease duration subgroups (78.3% vs. 78.0%). Neurological abnormalities were significantly more common in the lower extremities compared to the upper extremities (67.27% vs. 49.09%, Conclusions: CPT showed moderate diagnostic accuracy for early unmyelinated (C) fibers detection, routine CPT screening in high-risk groups (central obesity/short disease duration) enables timely intervention to prevent irreversible damage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.